134 related articles for article (PubMed ID: 22576626)
21. Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes.
Hie M; Tsukamoto I
Int J Mol Med; 2010 Oct; 26(4):611-8. PubMed ID: 20818503
[TBL] [Abstract][Full Text] [Related]
22. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
23. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
Shim KS; Ma CJ; Kim DS; Ma JY
J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
[TBL] [Abstract][Full Text] [Related]
24. The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF).
Bronisz A; Carey HA; Godlewski J; Sif S; Ostrowski MC; Sharma SM
J Biol Chem; 2014 Jan; 289(1):326-34. PubMed ID: 24257758
[TBL] [Abstract][Full Text] [Related]
25. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis.
Nakasa T; Shibuya H; Nagata Y; Niimoto T; Ochi M
Arthritis Rheum; 2011 Jun; 63(6):1582-90. PubMed ID: 21425254
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
28. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss.
Liu C; Guan H; Cai C; Li F; Xiao J
Exp Cell Res; 2017 Mar; 352(2):293-303. PubMed ID: 28209487
[TBL] [Abstract][Full Text] [Related]
29. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.
Sharma SM; Sif S; Ostrowski MC; Sankar U
J Cell Physiol; 2009 Jul; 220(1):230-7. PubMed ID: 19288495
[TBL] [Abstract][Full Text] [Related]
30. Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor.
Geng DC; Zhu XS; Mao HQ; Meng B; Chen L; Yang HL; Xu YZ
J Biomed Mater Res A; 2011 Dec; 99(4):516-22. PubMed ID: 21913318
[TBL] [Abstract][Full Text] [Related]
31. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
32. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
33. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
[TBL] [Abstract][Full Text] [Related]
34. Regulation of receptor activator of NF-kappaB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor.
Matsumoto M; Hisatake K; Nogi Y; Tsujimoto M
J Biol Chem; 2001 Aug; 276(35):33086-92. PubMed ID: 11425859
[TBL] [Abstract][Full Text] [Related]
35. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
36. High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells.
Mozar A; Haren N; Chasseraud M; Louvet L; Mazière C; Wattel A; Mentaverri R; Morlière P; Kamel S; Brazier M; Mazière JC; Massy ZA
J Cell Physiol; 2008 Apr; 215(1):47-54. PubMed ID: 17894387
[TBL] [Abstract][Full Text] [Related]
37. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
[TBL] [Abstract][Full Text] [Related]
38. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation.
Partington GA; Fuller K; Chambers TJ; Pondel M
Bone; 2004 Feb; 34(2):237-45. PubMed ID: 14962802
[TBL] [Abstract][Full Text] [Related]
39. Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways.
Sapkota M; Li L; Choi H; Gerwick WH; Soh Y
Eur J Pharmacol; 2015 Dec; 769():100-9. PubMed ID: 26550952
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells.
Xu XY; Guo C; Yan YX; Guo Y; Li RX; Song M; Zhang XZ
Mol Med Rep; 2012 Aug; 6(2):409-15. PubMed ID: 22580758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
